Suppr超能文献

经 radiosurgery 治疗后天脑动静脉畸形患者外周血中的基因表达谱。

Gene expression signatures in the peripheral blood after radiosurgery of human cerebral arteriovenous malformations.

机构信息

Department of Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.

Department of RadioOncology, University of Heidelberg, Heidelberg, Germany.

出版信息

Strahlenther Onkol. 2010 Feb;186(2):91-98. doi: 10.1007/s00066-010-2034-4. Epub 2010 Jan 28.

Abstract

PURPOSE

To unravel biological mechanisms potentially resulting in the obliteration process after radiosurgery (RS) of human cerebral arteriovenous malformations (AVMs) by investigating molecular signatures on the transcriptomic level in peripheral blood of patients.

PATIENTS AND METHODS

Venous blood samples were obtained at definite points of time before and after RS. The samples were tested for radiation-induced changes regarding biological markers (mRNA) using cDNA and oligo-microarray technology. The corresponding expression profiles were correlated with clinical data and obliteration signs in radiologic imaging.

RESULTS

The proof of principle that RS outcome can be successfully correlated with transcriptomics of cellular blood components as disease parameter was demonstrated. The authors identified 76 differentially regulated genes (p < 0.001) after RS. Interestingly, in particular genes with known roles in anti-angiogenic and pro-coagulative pathways were identified as potentially relevant. In particularly, the authors found a significant downregulation of neuropilin-2, protein C inhibitor and cyclin-dependent kinase 6. They also found that low pretreatment blood mRNA levels of TLR4 (toll-like receptor 4) and STAT3 (signal transducer and activator of transcription 3) correlated with fast obliteration of AVMs.

CONCLUSION

The authors report on a novel technique for molecular biological analysis of blood from patients with cerebral AVM treated with RS. Differential regulation of genes in peripheral blood was successfully correlated with RS and time to obliteration of AVMs. The identified genes indicate a potential new methodology to monitor RS, which may result in an individualized therapy and optimized follow-up.

摘要

目的

通过研究放射外科(RS)治疗后天脑动静脉畸形(AVM)患者外周血的转录组水平的分子特征,揭示潜在的生物学机制导致 RS 后闭塞过程。

方法

在 RS 前后的特定时间点采集静脉血样本。使用 cDNA 和寡微阵列技术测试样本中与生物标志物(mRNA)相关的辐射诱导变化。将相应的表达谱与临床数据和影像学中的闭塞迹象相关联。

结果

证明了 RS 结果可以成功地与细胞血液成分的转录组学作为疾病参数相关联的原理。作者鉴定出 RS 后 76 个差异调节基因(p<0.001)。有趣的是,特别是在抗血管生成和促凝途径中具有已知作用的特定基因被认为是潜在相关的。特别是,作者发现神经钙蛋白-2、蛋白 C 抑制剂和细胞周期蛋白依赖性激酶 6的显著下调。他们还发现,TLR4(toll-like receptor 4)和 STAT3(signal transducer and activator of transcription 3)的预处理血液 mRNA 水平低与 AVM 的快速闭塞相关。

结论

作者报告了一种用于分析接受 RS 治疗的后天性脑 AVM 患者血液的分子生物学新技术。外周血中基因的差异调节与 RS 和 AVM 闭塞时间成功相关。鉴定出的基因表明了一种监测 RS 的潜在新方法,可能导致个体化治疗和优化随访。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验